LEADER 06093nam 22005775 450 001 9910799278103321 005 20240326115210.0 010 $a3-031-33533-3 024 7 $a10.1007/978-3-031-33533-4 035 $a(MiAaPQ)EBC31063522 035 $a(Au-PeEL)EBL31063522 035 $a(DE-He213)978-3-031-33533-4 035 $a(OCoLC)1417759619 035 $a(CKB)29576133600041 035 $a(EXLCZ)9929576133600041 100 $a20240105d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBeyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum /$fedited by Vikas Prasad 205 $a1st ed. 2024. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2024. 215 $a1 online resource (367 pages) 311 08$aPrint version: Prasad, Vikas Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum Cham : Springer International Publishing AG,c2024 9783031335327 327 $a1. The Rise of A Theranostic Empire: Good Governance and Precision Oncology -- 2. 18 FDG PET CT assessing Inmunotherapy response -- 3. Radionuclide Therapy in Brain Tumours -- 4. From Concept to Clinic and Comercialisation - Cowboys Wanted -- 5. From Radiochemistry of the Lanthanides to 225Ac and the interference with Richard Baum -- 6. How do you feel about dosimetry?" The Gretchenfrage of Radionuclide Therapy -- 7. The LuGenIum Triptych Ode to a Theranostic Transcriptome -- 8. A tree can be recognized by its fruit -- 9. IAEA Strategy for Enhancing the Sustainability of Nuclear Medicine in Low- and Middle- Income Countries -- 10. Combining surgery with peptide receptor radionuclide therapy ? a step forward in treatment of advanced neuroendocrine tumours -- 11. Modern diagnostic and therapeutic approaches in thyroid diseases - Theranostics and the changing role of radioactive isotopes ? -- 12. Cardiotoxicity of targeted therapies: Imaging of Heart Does Matter -- 13. Following the co-evolution of Innovation and demand in the field of precision oncology -- 14. Fighting for PET in German oncological guidelines and for its reimbursement by Statutory Health Insurances -- 15. Precision Oncology with PSMA-targeted Alpha Particle Therapy of mCRPC -- 16. From Radioimmunodetection to Radiomolecular Precision Oncology via Radionanotargeting by Intelligent Multidisciplinary Radiotheragnostic Nanoparticles -- 17. Nuclear medicine and surgery a new productive new marriage -- 18. 'PSMA Radioligand Therapy - A Revolution in the Precision Oncology of Prostate Cancer' -- 19. The Role of Individuals for Innovation: The Nuclear Medicine Biotope -- 20. Working at ISOTOPENTHERAPIESTATION D3- a daily challenge or adventure never stops -- 21. Combining targeted radiation therapies in modern clinical oncological practice -- 22. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening & Clinical Translation -- 23. Terbium ?Sisters?: More than just a ?Swiss Army Knife? -- 24. High-Performance Radiopharmacy - The Base for Precision Oncology -- 25. Analyzing the science footprint of Richard P. Baum -- 26. Ac-225 PSMA in metastatic prostate cancer without previous chemotherapy -- 27. 'Sola dosis facit venenum: Dosimetrie in Precision Oncology with Radiolabelled Probe' -- 28. theranostic pair 203Pb and 212Pb for image-guided alpha/beta particle therapy for cancer. -- 29. Radioiodine labeled metaiodobenzylguanidine for imaging and treatment of the adrenal medulla and extra-adrenal paraganglia tumors -- 30. A (188)Re-juvenatiNG JOURNEY WITH HERCULES -- 31. CXCR4 Theranostic Experience from India -- 32. Can VPAC Targeted Cu-67-TP3805 Play a Theranostic Role for Prostate Cancer?: A Quest -- 33. REAL-WORLD EVIDENCE: CLINICAL OUTCOMES IN PRECISION RADIONUCLIDE ONCOLOGY. The WARMTH NIGHTCAP Study of 177Lu-PSMA in Metastatic Prostate Cancer. -- 34. Uptake of 68Ga-DOTATATE and 68Ga-DOTATOC in primary neuroendocrine tumors, metastases, and normal liver tissue ? isthere a significant difference? -- 35. Theranostics with somatostatin receptor antagonists. -- 36. Molecular in-vitro & in-vivo diagnostics as the impartible basis of multimodal therapy approaches in precision oncology -- 37. Molecular imaging platform and radio-pharmaceutical transnational research on Peking University Cancer Hospital -- 38. Dose it possible to targeting HER2 using Affibody receptor radionuclide therapy. 330 $aThis open access book is written by world-renowned experts on radiomolecular precision oncology to celebrate the work, life, principles and ideology of Richard P. Baum. It includes commentaries, reviews and some thought provoking novel ideas on radionuclide precision oncology, covering topics such as various aspects of theranostics and molecular radiotherapy like radiolabeled peptides, radiolabeled antibodies, dosimetry, and quality control as well as the diagnosis and treatment of specific tumor types. Featuring contributions by biologists, physicists, chemists, mathematicians, geneticists, and physicians from a range of specialties, this Festschrift is highly interdisciplinary and will be a valuable resource for future precision oncologists. . 606 $aNuclear medicine 606 $aMedical radiology 606 $aOncology 606 $aInternal medicine 606 $aNuclear Medicine 606 $aRadiation Oncology 606 $aInternal Medicine 615 0$aNuclear medicine. 615 0$aMedical radiology. 615 0$aOncology. 615 0$aInternal medicine. 615 14$aNuclear Medicine. 615 24$aRadiation Oncology. 615 24$aInternal Medicine. 676 $a616.0757 700 $aPrasad$b Vikas$01585508 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910799278103321 996 $aBeyond Becquerel and Biology to Precision Radiomolecular Oncology$93870691 997 $aUNINA LEADER 03386nam 22007815 450 001 9910373890003321 005 20250610110612.0 010 $a9783030369415 010 $a3030369412 024 7 $a10.1007/978-3-030-36941-5 035 $a(CKB)4100000010122052 035 $a(MiAaPQ)EBC6031658 035 $a(DE-He213)978-3-030-36941-5 035 $a(PPN)242847692 035 $a(Perlego)3480318 035 $a(MiAaPQ)EBC29158740 035 $a(EXLCZ)994100000010122052 100 $a20200128d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aColin Sumner $eCriminology Through the Looking-Glass /$fby David Moxon 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Palgrave Pivot,$d2020. 215 $a1 online resource (vii, 155 pages) 225 1 $aPalgrave Pioneers in Criminology,$x2946-5648 311 08$a9783030369408 311 08$a3030369404 320 $aIncludes bibliographical references and index. 327 $a1. Introduction -- 2. Sumner and Ideological Censure -- 3. After Censure -- 4. Sumner and the Death of Deviance -- 5. After the Death of Deviance -- 6. Sumner and the Looking Glass -- 7. After Sumner?. 330 $aThis book explores the work of criminologist Colin Sumner. It re-presents his arguments and ideas on Marxism, ideology, censure, deviance, crime, underdevelopment, social control and the media; situating them in their wider social context. Moxon argues that Sumner should be restored within the criminology discipline as a pioneer who has produced works of great theoretical sophistication and insight. By systematically considering Sumner's entire output, the book shows how his thought involved a gradually deepening understanding of his core notion of ideological censure. His writing is also marked by a growing unease with the effects of late modern capitalism and the quagmire of censoriousness rife in the 21st century. This book makes clear that Sumner's work was remarkably prescient, and his ideas may help up to make sense of complicated times. 410 0$aPalgrave Pioneers in Criminology,$x2946-5648 606 $aCritical criminology 606 $aCriminology 606 $aSociology 606 $aCrime$xSociological aspects 606 $aMass media and crime 606 $aCriminal behavior 606 $aCritical Criminology 606 $aCriminology Theory 606 $aSociological Theory 606 $aCrime and Society 606 $aCrime and the Media 606 $aCriminal Behavior 615 0$aCritical criminology. 615 0$aCriminology. 615 0$aSociology. 615 0$aCrime$xSociological aspects. 615 0$aMass media and crime. 615 0$aCriminal behavior. 615 14$aCritical Criminology. 615 24$aCriminology Theory. 615 24$aSociological Theory. 615 24$aCrime and Society. 615 24$aCrime and the Media. 615 24$aCriminal Behavior. 676 $a364 676 $a364.92 700 $aMoxon$b David$4aut$4http://id.loc.gov/vocabulary/relators/aut$0788354 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910373890003321 996 $aColin Sumner$91757176 997 $aUNINA